Viewing Opinion | StockChase
Abbott Labs (ABT-N) opinion on 2012-05-09

Last Price Recorded: 56.1200 on 2017-11-21

ON STOCKCHASE SINCE Jan 2001

biotechnology/pharmaceutical
WAIT

Gordon Reid
Abbott Labs was $61.230 at time of opinion
Owned : No

(Market Call Minute.) Splitting in two. Their pharma business is going to be priced more cheaply but be careful because their major drug is 47% of this. To concentrated. He would look at the other piece when they split.
BULLISH on US MARKET

All opinions for ABT-N (106)

30 BUY
5 BUY on WEAKNESS
17 COMMENT
7 DON'T BUY
6 HOLD
14 PAST TOP PICK
1 SELL
1 SELL ON STRENGTH
23 TOP PICK
2 WAIT
View All

More experts covering ABT-N

SAVE
Add ABT-N to Watch List

All opinions for ABT-N (106)

30 BUY
5 BUY on WEAKNESS
17 COMMENT
7 DON'T BUY
6 HOLD
14 PAST TOP PICK
1 SELL
1 SELL ON STRENGTH
23 TOP PICK
2 WAIT
View All

More experts covering ABT-N

SAVE
Add ABT-N to Watch List

No Comments.


You must be logged in to comment.

Successfully Saved Company